JATT Acquisition Corp’s Lock-Up Period To Expire on October 14th (NYSE:JATT)

JATT Acquisition’s (NYSE:JATT) lock-up period is set to end on Wednesday, October 14th. JATT Acquisition had issued 6,000,000 shares in its initial public offering on April 17th. The total size of the offering was $60,000,000 based on an initial share price of $10.00. After the expiration of the company’s lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

JATT Acquisition Stock Performance

Shares of JATT stock opened at $10.56 on Friday. The business has a fifty day moving average of $12.06 and a 200 day moving average of $10.62. JATT Acquisition has a 1 year low of $9.99 and a 1 year high of $23.76.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in JATT Acquisition stock. Spruce Street Capital LP bought a new position in shares of JATT Acquisition Corp (NYSE:JATT) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 160,000 shares of the company’s stock, valued at approximately $1,817,600. Spruce Street Capital LP owned 1.99% of JATT Acquisition as of its most recent SEC filing. Institutional investors own 47.97% of the company’s stock.

JATT Acquisition Company Profile

JATT Acquisition Corp. was a special purpose acquisition company formed to identify and complete a business combination with a company in the healthcare, biotechnology, pharmaceutical or medical-device sectors. As a blank-check company, it did not operate a commercial business or offer products and services of its own before completing a transaction.

JATT announced a business combination with Zura Bio Limited, a biotechnology company developing medicines for immune-mediated diseases. The transaction was completed in 2023, after which the combined company operated under the Zura Bio name and JATT Acquisition Corp.